Pursuing Deeper Understanding about the Most Common Type of Heart Failure
Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF) and at the forefront of HFpEF research are Feinberg investigators.
Nanoparticle-Based COVID-19 Vaccine Could Target Future Infectious Diseases
A new publication outlines the structure-function relationships between the first spherical nucleic acid vaccine developed to protect against viral infections, including COVID-19.
Feinberg Hosts 2022 Research Retreat
Nearly 200 principal investigators gathered recently at the Fairmont Hotel for discussion and brainstorming to generate the research priorities that will help guide the Feinberg research enterprise for the next five years.